DMAC - Historical Earnings Price Analysis
Source: KlickAnalytics
2025-05-12 18:43:11 ET
DiaMedica Therapeutics Inc. (DMAC) - Following Earnings Price Analysis was done using last 12 quarters historical earnings.
Opening Gap Moves
Actual Earning Moves
Full story available on KlickAnalytics.com
DiaMedica Therapeutics Inc.
NASDAQ: DMAC
DMAC Trading
-5.35% G/L:
$7.07 Last:
92,570 Volume:
$7.32 Open:
DMAC Latest News
March 05, 2026 07:35:00 am
DiaMedica Therapeutics Receives Health Canada Clearance to Initiate Phase 2 Study of DM199 in Preeclampsia
February 24, 2026 09:23:00 am
DiaMedica Therapeutics to Participate in Upcoming March Investor Conferences
January 16, 2026 05:00:00 pm
DiaMedica Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 18, 2025 08:45:00 am
DiaMedica Therapeutics Provides DM199 Preeclampsia Program Update Following Pre-IND Meeting with FDA
DMAC Stock Data
$439,533,585
29,684,140
16.95%
29
N/A
Biotechnology & Life Sciences
Healthcare
US
Minneapolis
